Pre-made Zolimomab Aritox benchmark antibody (ADC, anti-CD5 therapeutic antibody, Anti-LEU1/T1 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-made Zolimomab Aritox benchmark antibody (ADC, anti-CD5 therapeutic antibody, Anti-LEU1/T1 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Zolimomab aritox is a mouse monoclonal antibody which has been investigated for the treatment of systemic lupus erythematosus[1] and graft-versus-host disease,[2] but the studies failed to show positive effects of the drug.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-1060-1mg	1mg	Inquiry
GMP-Bios-INN-1060-10mg	10mg	Inquiry
GMP-Bios-INN-1060-100mg	100mg	Inquiry
GMP-Bios-INN-1060-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Zolimomab Aritox Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody: Anti-LEU1/T1 therapeutic antibody
INN Name	Zolimomab Aritox
Target	CD5
Format	ADC
Derivation	Mus musculus
Species Reactivity	human
CH1 Isotype	IgG1 - nd
VD LC	IgG1 - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	0
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0